1. Home
  2. BMR vs LPCN Comparison

BMR vs LPCN Comparison

Compare BMR & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

N/A

Current Price

$1.28

Market Cap

19.3M

Sector

Technology

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$2.07

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMR
LPCN
Founded
2009
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
18.7M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
BMR
LPCN
Price
$1.28
$2.07
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
26.4K
★ 31.0K
Earning Date
08-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,976,677.00
Revenue This Year
$0.19
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.06
$1.81
52 Week High
$3.24
$12.37

Technical Indicators

Market Signals
Indicator
BMR
LPCN
Relative Strength Index (RSI) N/A 49.10
Support Level N/A $2.16
Resistance Level N/A $2.27
Average True Range (ATR) 0.00 0.10
MACD 0.00 -0.01
Stochastic Oscillator 0.00 54.79

Price Performance

Historical Comparison
BMR
LPCN

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: